Orgenesis (ORGS) Stock Price
Orgenesis Price
Revenue at Orgenesis has contracted by 11.1% per year over the past 9 years to 1.04 M USD. For Orgenesis, the net margin of -4,653.6% is down versus -1,252.1% a few years ago.
Orgenesis stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Orgenesis business model & stock analysis
Frequently asked questions about Orgenesis
7 analysts currently rate the Orgenesis stock: 6 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Orgenesis share trades at 0.04 EUR (0.05 USD).
The Orgenesis share (ORGS) is listed on 2 stock exchanges, including: NASDAQ (ORGS), Frankfurt (45O.F).
The revenue cannot currently be calculated for Orgenesis.
The profit cannot currently be calculated for Orgenesis.
The P/E ratio cannot be calculated for Orgenesis at the moment.
The P/S cannot be calculated for Orgenesis currently.
The Eulerpool Quality Score for Orgenesis is 5/10.
The ISIN of Orgenesis is US68619K3032. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Orgenesis is A2H7XQ. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Orgenesis is ORGS. The ticker symbol is used to trade Orgenesis shares on the stock exchange.
Orgenesis stock
Orgenesis Peer Group
Orgenesis Ticker
All fundamentals and in-depth analysis of Orgenesis
Our stock analysis for Orgenesis stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Orgenesis. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.